APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tablet and Capsule Budesonide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tablet and Capsule Budesonide Industry Growth and Trends Forecast to 2032

19 December 2025101 pages

Choose your research edition.

Industry ResearchTablet and Capsule Budesonide Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Tablet and Capsule Budesonide Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Tablet and Capsule Budesonide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tablet and Capsule Budesonide Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Tablet and Capsule Budesonide Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Tablet and Capsule Budesonide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tablet and Capsule Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tablet and Capsule Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tablet and Capsule Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tablet and Capsule Budesonide include Chiesi Farmaceutici, Cipla, Cosmo Pharmaceuticals, Orion Corporation, Salix, AstraZeneca, Synmosa Biopharma, Lunan Better Pharma and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tablet and Capsule Budesonide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tablet and Capsule Budesonide market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tablet and Capsule Budesonide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tablet and Capsule Budesonide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tablet and Capsule Budesonide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tablet and Capsule Budesonide Market by Company

Chiesi Farmaceutici

Cipla

Cosmo Pharmaceuticals

Orion Corporation

Salix

AstraZeneca

Synmosa Biopharma

Lunan Better Pharma

Mylan

Sandoz

Shanghai Sine Promod

Teva

Tablet and Capsule Budesonide Segment by Type

Tablet

Capsule

Tablet and Capsule Budesonide Segment by Application

Inflammatory Bowel Disease Treatment

Respiratory Disease Treatment

Nose Disease Treatment

Other

Tablet and Capsule Budesonide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tablet and Capsule Budesonide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tablet and Capsule Budesonide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tablet and Capsule Budesonide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tablet and Capsule Budesonide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tablet and Capsule Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Capsule Table 3. Global Tablet and Capsule Budesonide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tablet and Capsule Budesonide Sales by Type (2021-2026) & (K Units) Table 5. Global Tablet and Capsule Budesonide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tablet and Capsule Budesonide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tablet and Capsule Budesonide Sales Market Share in Value by Type (2021-2026) Table 8. Global Tablet and Capsule Budesonide Price by Type (2021-2026) & (US$/Unit) Table 9. Global Tablet and Capsule Budesonide Sales by Type (2027-2032) & (K Units) Table 10. Global Tablet and Capsule Budesonide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tablet and Capsule Budesonide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tablet and Capsule Budesonide Sales Market Share in Value by Type (2027-2032) Table 13. Global Tablet and Capsule Budesonide Price by Type (2027-2032) & (US$/Unit) Table 14. North America Tablet and Capsule Budesonide Sales by Type (2021-2026) & (K Units) Table 15. North America Tablet and Capsule Budesonide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tablet and Capsule Budesonide Sales by Type (2021-2026) & (K Units) Table 17. Europe Tablet and Capsule Budesonide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tablet and Capsule Budesonide Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Tablet and Capsule Budesonide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tablet and Capsule Budesonide Sales by Type (2021-2026) & (K Units) Table 21. Latin America Tablet and Capsule Budesonide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tablet and Capsule Budesonide Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Tablet and Capsule Budesonide Sales by Type (2021-2026) & (US$ Million) Table 24. Tablet and Capsule Budesonide Industry Trends Table 25. Tablet and Capsule Budesonide Industry Drivers Table 26. Tablet and Capsule Budesonide Industry Opportunities and Challenges Table 27. Tablet and Capsule Budesonide Industry Restraints Table 28. Global Tablet and Capsule Budesonide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tablet and Capsule Budesonide Revenue Market Share by Company (2021-2026) Table 30. Global Tablet and Capsule Budesonide Sales by Company (2021-2026) & (K Units) Table 31. Global Tablet and Capsule Budesonide Sales Share by Company (2021-2026) Table 32. Global Tablet and Capsule Budesonide Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Tablet and Capsule Budesonide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tablet and Capsule Budesonide Major Company Production Sites and Headquarters Table 35. Global Tablet and Capsule Budesonide Company, Product Type & Application Table 36. Global Tablet and Capsule Budesonide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tablet and Capsule Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tablet and Capsule Budesonide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tablet and Capsule Budesonide Sales by Region (2021-2026) & (K Units) Table 41. Global Tablet and Capsule Budesonide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tablet and Capsule Budesonide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tablet and Capsule Budesonide Sales Market Share in Value by Region (2021-2026) Table 44. Global Tablet and Capsule Budesonide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Tablet and Capsule Budesonide Sales by Region (2027-2032) & (K Units) Table 46. Global Tablet and Capsule Budesonide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tablet and Capsule Budesonide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tablet and Capsule Budesonide Sales Market Share in Value by Region (2027-2032) Table 49. Global Tablet and Capsule Budesonide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Tablet and Capsule Budesonide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tablet and Capsule Budesonide Sales by Application (2021-2026) & (K Units) Table 52. Global Tablet and Capsule Budesonide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tablet and Capsule Budesonide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tablet and Capsule Budesonide Sales Market Share in Value by Application (2021-2026) Table 55. Global Tablet and Capsule Budesonide Price by Application (2021-2026) & (US$/Unit) Table 56. Global Tablet and Capsule Budesonide Sales by Application (2027-2032) & (K Units) Table 57. Global Tablet and Capsule Budesonide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tablet and Capsule Budesonide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tablet and Capsule Budesonide Sales Market Share in Value by Application (2027-2032) Table 60. Global Tablet and Capsule Budesonide Price by Application (2027-2032) & (US$/Unit) Table 61. North America Tablet and Capsule Budesonide Sales by Application (2021-2026) & (K Units) Table 62. North America Tablet and Capsule Budesonide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tablet and Capsule Budesonide Sales by Application (2021-2026) & (K Units) Table 64. Europe Tablet and Capsule Budesonide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tablet and Capsule Budesonide Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Tablet and Capsule Budesonide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tablet and Capsule Budesonide Sales by Application (2021-2026) & (K Units) Table 68. Latin America Tablet and Capsule Budesonide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tablet and Capsule Budesonide Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Tablet and Capsule Budesonide Sales by Application (2021-2026) & (US$ Million) Table 71. Chiesi Farmaceutici Company Information Table 72. Chiesi Farmaceutici Business Overview Table 73. Chiesi Farmaceutici Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chiesi Farmaceutici Tablet and Capsule Budesonide Product Portfolio Table 75. Chiesi Farmaceutici Recent Development Table 76. Cipla Company Information Table 77. Cipla Business Overview Table 78. Cipla Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Cipla Tablet and Capsule Budesonide Product Portfolio Table 80. Cipla Recent Development Table 81. Cosmo Pharmaceuticals Company Information Table 82. Cosmo Pharmaceuticals Business Overview Table 83. Cosmo Pharmaceuticals Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Cosmo Pharmaceuticals Tablet and Capsule Budesonide Product Portfolio Table 85. Cosmo Pharmaceuticals Recent Development Table 86. Orion Corporation Company Information Table 87. Orion Corporation Business Overview Table 88. Orion Corporation Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Orion Corporation Tablet and Capsule Budesonide Product Portfolio Table 90. Orion Corporation Recent Development Table 91. Salix Company Information Table 92. Salix Business Overview Table 93. Salix Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Salix Tablet and Capsule Budesonide Product Portfolio Table 95. Salix Recent Development Table 96. AstraZeneca Company Information Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. AstraZeneca Tablet and Capsule Budesonide Product Portfolio Table 100. AstraZeneca Recent Development Table 101. Synmosa Biopharma Company Information Table 102. Synmosa Biopharma Business Overview Table 103. Synmosa Biopharma Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Synmosa Biopharma Tablet and Capsule Budesonide Product Portfolio Table 105. Synmosa Biopharma Recent Development Table 106. Lunan Better Pharma Company Information Table 107. Lunan Better Pharma Business Overview Table 108. Lunan Better Pharma Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Lunan Better Pharma Tablet and Capsule Budesonide Product Portfolio Table 110. Lunan Better Pharma Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mylan Tablet and Capsule Budesonide Product Portfolio Table 115. Mylan Recent Development Table 116. Sandoz Company Information Table 117. Sandoz Business Overview Table 118. Sandoz Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sandoz Tablet and Capsule Budesonide Product Portfolio Table 120. Sandoz Recent Development Table 121. Shanghai Sine Promod Company Information Table 122. Shanghai Sine Promod Business Overview Table 123. Shanghai Sine Promod Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Shanghai Sine Promod Tablet and Capsule Budesonide Product Portfolio Table 125. Shanghai Sine Promod Recent Development Table 126. Teva Company Information Table 127. Teva Business Overview Table 128. Teva Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Teva Tablet and Capsule Budesonide Product Portfolio Table 130. Teva Recent Development Table 131. North America Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Tablet and Capsule Budesonide Sales by Country (2021-2026) & (K Units) Table 133. North America Tablet and Capsule Budesonide Sales Market Share by Country (2021-2026) Table 134. North America Tablet and Capsule Budesonide Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Tablet and Capsule Budesonide Sales Market Share Forecast by Country (2027-2032) Table 136. North America Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Tablet and Capsule Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Tablet and Capsule Budesonide Market Share by Country (2021-2026) Table 139. North America Tablet and Capsule Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Tablet and Capsule Budesonide Market Share Forecast by Country (2027-2032) Table 141. Europe Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Tablet and Capsule Budesonide Sales by Country (2021-2026) & (K Units) Table 143. Europe Tablet and Capsule Budesonide Sales Market Share by Country (2021-2026) Table 144. Europe Tablet and Capsule Budesonide Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Tablet and Capsule Budesonide Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Tablet and Capsule Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Tablet and Capsule Budesonide Market Share by Country (2021-2026) Table 149. Europe Tablet and Capsule Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Tablet and Capsule Budesonide Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Tablet and Capsule Budesonide Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Tablet and Capsule Budesonide Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Tablet and Capsule Budesonide Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Tablet and Capsule Budesonide Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Tablet and Capsule Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Tablet and Capsule Budesonide Market Share by Country (2021-2026) Table 159. Asia-Pacific Tablet and Capsule Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Tablet and Capsule Budesonide Market Share Forecast by Country (2027-2032) Table 161. Latin America Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Tablet and Capsule Budesonide Sales by Country (2021-2026) & (K Units) Table 163. Latin America Tablet and Capsule Budesonide Sales Market Share by Country (2021-2026) Table 164. Latin America Tablet and Capsule Budesonide Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Tablet and Capsule Budesonide Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Tablet and Capsule Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Tablet and Capsule Budesonide Market Share by Country (2021-2026) Table 169. Latin America Tablet and Capsule Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Tablet and Capsule Budesonide Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Tablet and Capsule Budesonide Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Tablet and Capsule Budesonide Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Tablet and Capsule Budesonide Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Tablet and Capsule Budesonide Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Tablet and Capsule Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Tablet and Capsule Budesonide Market Share by Country (2021-2026) Table 179. Middle East and Africa Tablet and Capsule Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Tablet and Capsule Budesonide Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Tablet and Capsule Budesonide Distributors List Table 184. Tablet and Capsule Budesonide Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Tablet and Capsule Budesonide Image Figure 2. Global Tablet and Capsule Budesonide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tablet and Capsule Budesonide Market Size (2021-2032) & (US$ Million) Figure 4. Global Tablet and Capsule Budesonide Sales (2021-2032) & (K Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsule Image Figure 8. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Tablet and Capsule Budesonide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tablet and Capsule Budesonide Market Share by Type 2025 VS 2032 Figure 11. North America Tablet and Capsule Budesonide Sales Market Share in Volume by Type in 2025 Figure 12. North America Tablet and Capsule Budesonide Sales Market Share in Value by Type in 2025 Figure 13. Europe Tablet and Capsule Budesonide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tablet and Capsule Budesonide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tablet and Capsule Budesonide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tablet and Capsule Budesonide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tablet and Capsule Budesonide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tablet and Capsule Budesonide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tablet and Capsule Budesonide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tablet and Capsule Budesonide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tablet and Capsule Budesonide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Inflammatory Bowel Disease Treatment Image Figure 24. Global Inflammatory Bowel Disease Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 25. Respiratory Disease Treatment Image Figure 26. Global Respiratory Disease Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 27. Nose Disease Treatment Image Figure 28. Global Nose Disease Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Tablet and Capsule Budesonide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Tablet and Capsule Budesonide Market Share by Application 2025 VS 2032 Figure 33. North America Tablet and Capsule Budesonide Sales Market Share in Volume by Application in 2025 Figure 34. North America Tablet and Capsule Budesonide Sales Market Share in Value by Application in 2025 Figure 35. Europe Tablet and Capsule Budesonide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Tablet and Capsule Budesonide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Tablet and Capsule Budesonide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Tablet and Capsule Budesonide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Tablet and Capsule Budesonide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Tablet and Capsule Budesonide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Tablet and Capsule Budesonide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Tablet and Capsule Budesonide Sales Market Share in Value by Application in 2025 Figure 43. North America Tablet and Capsule Budesonide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Tablet and Capsule Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Tablet and Capsule Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Tablet and Capsule Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tablet and Capsule Budesonide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Tablet and Capsule Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Tablet and Capsule Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Tablet and Capsule Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tablet and Capsule Budesonide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Tablet and Capsule Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Tablet and Capsule Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Tablet and Capsule Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tablet and Capsule Budesonide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Tablet and Capsule Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Tablet and Capsule Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Tablet and Capsule Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tablet and Capsule Budesonide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Tablet and Capsule Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Tablet and Capsule Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Tablet and Capsule Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Tablet and Capsule Budesonide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Tablet and Capsule Budesonide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Inflammatory Bowel Disease Treatment
  • Respiratory Disease Treatment
  • Nose Disease Treatment
  • Other
Companies covered
  • Chiesi Farmaceutici
  • Cipla
  • Cosmo Pharmaceuticals
  • Orion Corporation
  • Salix
  • AstraZeneca
  • Synmosa Biopharma
  • Lunan Better Pharma
  • Mylan
  • Sandoz
  • Shanghai Sine Promod
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tablet and Capsule Budesonide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tablet and Capsule Budesonide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tablet and Capsule Budesonide Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Capsule
  8. 1.4 Global Tablet and Capsule Budesonide Market Size by Type
  9. 1.4.1 Global Tablet and Capsule Budesonide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tablet and Capsule Budesonide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tablet and Capsule Budesonide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tablet and Capsule Budesonide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tablet and Capsule Budesonide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tablet and Capsule Budesonide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tablet and Capsule Budesonide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tablet and Capsule Budesonide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tablet and Capsule Budesonide Industry Trends
  2. 2.2 Tablet and Capsule Budesonide Industry Drivers
  3. 2.3 Tablet and Capsule Budesonide Industry Opportunities and Challenges
  4. 2.4 Tablet and Capsule Budesonide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tablet and Capsule Budesonide Revenue (2021-2026)
  2. 3.2 Global Top Players by Tablet and Capsule Budesonide Sales (2021-2026)
  3. 3.3 Global Top Players by Tablet and Capsule Budesonide Price (2021-2026)
  4. 3.4 Global Tablet and Capsule Budesonide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tablet and Capsule Budesonide Major Company Production Sites & Headquarters
  6. 3.6 Global Tablet and Capsule Budesonide Company, Product Type & Application
  7. 3.7 Global Tablet and Capsule Budesonide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tablet and Capsule Budesonide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tablet and Capsule Budesonide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tablet and Capsule Budesonide Tier 1, Tier 2, and Tier 3
4 Tablet and Capsule Budesonide Regional Status and Outlook
  1. 4.1 Global Tablet and Capsule Budesonide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tablet and Capsule Budesonide Historic Market Size by Region
  3. 4.2.1 Global Tablet and Capsule Budesonide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tablet and Capsule Budesonide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tablet and Capsule Budesonide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tablet and Capsule Budesonide Forecasted Market Size by Region
  7. 4.3.1 Global Tablet and Capsule Budesonide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tablet and Capsule Budesonide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tablet and Capsule Budesonide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tablet and Capsule Budesonide by Application
  1. 5.1 Tablet and Capsule Budesonide Market by Application
  2. 5.1.1 Inflammatory Bowel Disease Treatment
  3. 5.1.2 Respiratory Disease Treatment
  4. 5.1.3 Nose Disease Treatment
  5. 5.1.4 Other
  6. 5.2 Global Tablet and Capsule Budesonide Market Size by Application
  7. 5.2.1 Global Tablet and Capsule Budesonide Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Tablet and Capsule Budesonide Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Tablet and Capsule Budesonide Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Tablet and Capsule Budesonide Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Tablet and Capsule Budesonide Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Tablet and Capsule Budesonide Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Tablet and Capsule Budesonide Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Tablet and Capsule Budesonide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chiesi Farmaceutici
  2. 6.1.1 Chiesi Farmaceutici Company Information
  3. 6.1.2 Chiesi Farmaceutici Business Overview
  4. 6.1.3 Chiesi Farmaceutici Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chiesi Farmaceutici Tablet and Capsule Budesonide Product Portfolio
  6. 6.1.5 Chiesi Farmaceutici Recent Developments
  7. 6.2 Cipla
  8. 6.2.1 Cipla Company Information
  9. 6.2.2 Cipla Business Overview
  10. 6.2.3 Cipla Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipla Tablet and Capsule Budesonide Product Portfolio
  12. 6.2.5 Cipla Recent Developments
  13. 6.3 Cosmo Pharmaceuticals
  14. 6.3.1 Cosmo Pharmaceuticals Company Information
  15. 6.3.2 Cosmo Pharmaceuticals Business Overview
  16. 6.3.3 Cosmo Pharmaceuticals Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cosmo Pharmaceuticals Tablet and Capsule Budesonide Product Portfolio
  18. 6.3.5 Cosmo Pharmaceuticals Recent Developments
  19. 6.4 Orion Corporation
  20. 6.4.1 Orion Corporation Company Information
  21. 6.4.2 Orion Corporation Business Overview
  22. 6.4.3 Orion Corporation Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Orion Corporation Tablet and Capsule Budesonide Product Portfolio
  24. 6.4.5 Orion Corporation Recent Developments
  25. 6.5 Salix
  26. 6.5.1 Salix Company Information
  27. 6.5.2 Salix Business Overview
  28. 6.5.3 Salix Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Salix Tablet and Capsule Budesonide Product Portfolio
  30. 6.5.5 Salix Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Tablet and Capsule Budesonide Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Synmosa Biopharma
  38. 6.7.1 Synmosa Biopharma Company Information
  39. 6.7.2 Synmosa Biopharma Business Overview
  40. 6.7.3 Synmosa Biopharma Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Synmosa Biopharma Tablet and Capsule Budesonide Product Portfolio
  42. 6.7.5 Synmosa Biopharma Recent Developments
  43. 6.8 Lunan Better Pharma
  44. 6.8.1 Lunan Better Pharma Company Information
  45. 6.8.2 Lunan Better Pharma Business Overview
  46. 6.8.3 Lunan Better Pharma Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lunan Better Pharma Tablet and Capsule Budesonide Product Portfolio
  48. 6.8.5 Lunan Better Pharma Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Tablet and Capsule Budesonide Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Sandoz
  56. 6.10.1 Sandoz Company Information
  57. 6.10.2 Sandoz Business Overview
  58. 6.10.3 Sandoz Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sandoz Tablet and Capsule Budesonide Product Portfolio
  60. 6.10.5 Sandoz Recent Developments
  61. 6.11 Shanghai Sine Promod
  62. 6.11.1 Shanghai Sine Promod Company Information
  63. 6.11.2 Shanghai Sine Promod Business Overview
  64. 6.11.3 Shanghai Sine Promod Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shanghai Sine Promod Tablet and Capsule Budesonide Product Portfolio
  66. 6.11.5 Shanghai Sine Promod Recent Developments
  67. 6.12 Teva
  68. 6.12.1 Teva Company Information
  69. 6.12.2 Teva Business Overview
  70. 6.12.3 Teva Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva Tablet and Capsule Budesonide Product Portfolio
  72. 6.12.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Tablet and Capsule Budesonide Sales by Country
  2. 7.1.1 North America Tablet and Capsule Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tablet and Capsule Budesonide Sales by Country (2021-2026)
  4. 7.1.3 North America Tablet and Capsule Budesonide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tablet and Capsule Budesonide Market Size by Country
  6. 7.2.1 North America Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tablet and Capsule Budesonide Market Size by Country (2021-2026)
  8. 7.2.3 North America Tablet and Capsule Budesonide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tablet and Capsule Budesonide Sales by Country
  2. 8.1.1 Europe Tablet and Capsule Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tablet and Capsule Budesonide Sales by Country (2021-2026)
  4. 8.1.3 Europe Tablet and Capsule Budesonide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tablet and Capsule Budesonide Market Size by Country
  6. 8.2.1 Europe Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tablet and Capsule Budesonide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tablet and Capsule Budesonide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tablet and Capsule Budesonide Sales by Country
  2. 9.1.1 Asia-Pacific Tablet and Capsule Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tablet and Capsule Budesonide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tablet and Capsule Budesonide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tablet and Capsule Budesonide Market Size by Country
  6. 9.2.1 Asia-Pacific Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tablet and Capsule Budesonide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tablet and Capsule Budesonide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tablet and Capsule Budesonide Sales by Country
  2. 10.1.1 South America Tablet and Capsule Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tablet and Capsule Budesonide Sales by Country (2021-2026)
  4. 10.1.3 South America Tablet and Capsule Budesonide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tablet and Capsule Budesonide Market Size by Country
  6. 10.2.1 South America Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tablet and Capsule Budesonide Market Size by Country (2021-2026)
  8. 10.2.3 South America Tablet and Capsule Budesonide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tablet and Capsule Budesonide Sales by Country
  2. 11.1.1 Middle East and Africa Tablet and Capsule Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tablet and Capsule Budesonide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tablet and Capsule Budesonide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tablet and Capsule Budesonide Market Size by Country
  6. 11.2.1 Middle East and Africa Tablet and Capsule Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tablet and Capsule Budesonide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tablet and Capsule Budesonide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tablet and Capsule Budesonide Value Chain Analysis
  2. 12.1.1 Tablet and Capsule Budesonide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tablet and Capsule Budesonide Production Mode & Process
  7. 12.2 Tablet and Capsule Budesonide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tablet and Capsule Budesonide Distributors
  10. 12.2.3 Tablet and Capsule Budesonide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst